Clinical Trials Logo

Pediatric Ulcerative Colitis clinical trials

View clinical trials related to Pediatric Ulcerative Colitis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04348890 Withdrawn - Clinical trials for Pediatric Ulcerative Colitis

Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis

Start date: September 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase I/II, multi-center, open-label proof-of-concept study of vamorolone. Twenty participants with a flare of mild or moderately active Ulcerative Colitis (defined as a Pediatric Ulcerative Colitis Activity Index [PUCAI] 10-60) will be enrolled and receive vamorolone 6 mg/kg/day orally once daily for 8 weeks.